← Home · All topics

Radical Numerics

2 GoKawiil briefs on this topic

Radical Numerics begins FDA-authorized trial of AI-designed phages on a patient

Startup Radical Numerics has started an FDA-authorized clinical trial using bacteriophages designed by artificial intelligence to treat a patient's infection. CEO Dr. Eric Nguyen says the approach could create a virus tailored to a specific infection in days, but the research has not yet been peer-reviewed and success is not guaranteed.

science.slashdot.org · 2026-10-22

Radical Numerics claims AI-designed virus treated a patient's bacterial infection

Startup Radical Numerics published a self-authored technical paper describing an AI-engineered bacteriophage used to treat a human patient's bacterial infection. The paper was not peer-reviewed or published in a scientific journal, and the company declined to share clinical details or identify the patient or doctors involved, citing proprietary concerns.

futurism.com · 2026-10-21